Free Trial
NASDAQ:PGNY

Progyny Q1 2025 Earnings Report

Progyny logo
$23.23 +0.43 (+1.89%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$22.94 -0.30 (-1.27%)
As of 05/2/2025 07:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Progyny EPS Results

Actual EPS
N/A
Consensus EPS
$0.45
Beat/Miss
N/A
One Year Ago EPS
N/A

Progyny Revenue Results

Actual Revenue
N/A
Expected Revenue
$307.86 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Progyny Announcement Details

Quarter
Q1 2025
Time
Before Market Opens
Conference Call Date
Thursday, May 8, 2025
Conference Call Time
4:45PM ET

Conference Call Resources

Progyny Earnings Headlines

Progyny appoints Melissa Cummings as COO, Geoffrey Clapp as CPO
Warning: “DOGE Collapse” imminent
Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead.
See More Progyny Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Progyny? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Progyny and other key companies, straight to your email.

About Progyny

Progyny (NASDAQ:PGNY), a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

View Progyny Profile

More Earnings Resources from MarketBeat